These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 22997989

  • 1. Utility of serum tartrate-resistant acid phosphatase isoform 5b, bone alkaline phosphatase and osteocalcin in osteoporotic fractures in Chinese patients.
    Cao Y, Liu X, Xu H.
    Clin Lab; 2012; 58(7-8):845-50. PubMed ID: 22997989
    [Abstract] [Full Text] [Related]

  • 2. A change of osteocalcin (OC) and tartrate resistant acid phosphatase 5b (TRACP-5b) with the menstrual cycle.
    Lee S, Kumagai T, Hashimoto J, Satoh A, Suzuki T, Yamai K, Ohta S.
    Horm Metab Res; 2012 Sep; 44(9):699-703. PubMed ID: 22517558
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth.
    Chen CJ, Chao TY, Janckila AJ, Cheng SN, Ku CH, Chu DM.
    J Pediatr Endocrinol Metab; 2005 Jan; 18(1):55-62. PubMed ID: 15679069
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients.
    Tang C, Liu Y, Qin H, Li X, Guo W, Li J, Wang W, Qu L, Hu H, Xu C, Zheng L, Huang Y, Liu B, Gao H, Halleen JM, Liu X.
    Clin Chim Acta; 2013 Nov 15; 426():102-7. PubMed ID: 24055775
    [Abstract] [Full Text] [Related]

  • 5. Altered levels of BMD, PRL, BAP and TRACP-5b in male chronic patients with schizophrenia.
    Du X, Ye F, Li J, Zhao Y, Xiao W, Tang X, Zhang X.
    Sci Rep; 2020 Aug 12; 10(1):13598. PubMed ID: 32788631
    [Abstract] [Full Text] [Related]

  • 6. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
    Terpos E, de la Fuente J, Szydlo R, Hatjiharissi E, Viniou N, Meletis J, Yataganas X, Goldman JM, Rahemtulla A.
    Int J Cancer; 2003 Sep 01; 106(3):455-7. PubMed ID: 12845688
    [Abstract] [Full Text] [Related]

  • 7. The association of bone metabolism with bone mineral density, serum sex hormone concentrations, and regular exercise in middle-aged men.
    Remes T, Väisänen SB, Mahonen A, Huuskonen J, Kröger H, Jurvelin JS, Penttilä IM, Rauramaa R.
    Bone; 2004 Aug 01; 35(2):439-47. PubMed ID: 15268895
    [Abstract] [Full Text] [Related]

  • 8. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density.
    Halleen JM, Ylipahkala H, Alatalo SL, Janckila AJ, Heikkinen JE, Suominen H, Cheng S, Väänänen HK.
    Calcif Tissue Int; 2002 Jul 01; 71(1):20-5. PubMed ID: 12073156
    [Abstract] [Full Text] [Related]

  • 9. Changes in bone mass and bone turnover following ankle fracture.
    Ingle BM, Hay SM, Bottjer HM, Eastell R.
    Osteoporos Int; 1999 Jul 01; 10(5):408-15. PubMed ID: 10591839
    [Abstract] [Full Text] [Related]

  • 10. Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis.
    Mederle OA, Balas M, Ioanoviciu SD, Gurban CV, Tudor A, Borza C.
    Clin Interv Aging; 2018 Jul 01; 13():1383-1389. PubMed ID: 30122910
    [Abstract] [Full Text] [Related]

  • 11. Bone turnover in passive smoking female rat: relationships to change in bone mineral density.
    Gao SG, Li KH, Xu M, Jiang W, Shen H, Luo W, Xu WS, Tian J, Lei GH.
    BMC Musculoskelet Disord; 2011 Jun 11; 12():131. PubMed ID: 21663694
    [Abstract] [Full Text] [Related]

  • 12. Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
    Mori Y, Kasai H, Ose A, Serada M, Ishiguro M, Shiraki M, Tanigawara Y.
    Osteoporos Int; 2018 May 11; 29(5):1155-1163. PubMed ID: 29423715
    [Abstract] [Full Text] [Related]

  • 13. Alternative immunoassay for tartrate-resistant acid phosphatase isoform 5b using the fluorogenic substrate naphthol ASBI-phosphate and heparin.
    Janckila AJ, Simons RM, Yam LT.
    Clin Chim Acta; 2004 Sep 11; 347(1-2):157-67. PubMed ID: 15313154
    [Abstract] [Full Text] [Related]

  • 14. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
    Małyszko J, Małyszko JS, Pawlak K, Wołczyński S, Myśliwiec M.
    Adv Med Sci; 2006 Sep 11; 51():69-72. PubMed ID: 17357281
    [Abstract] [Full Text] [Related]

  • 15. Tartrate-Resistant Acid Phosphatase 5b in Young Patients With Sickle Cell Disease and Trait Siblings: Relation to Vasculopathy and Bone Mineral Density.
    Mokhtar GM, Tantawy AA, Hamed AA, Adly AA, Ismail EA, Makkeyah SM.
    Clin Appl Thromb Hemost; 2017 Jan 11; 23(1):64-71. PubMed ID: 26149452
    [Abstract] [Full Text] [Related]

  • 16. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity.
    Janckila AJ, Takahashi K, Sun SZ, Yam LT.
    Clin Chem; 2001 Jan 11; 47(1):74-80. PubMed ID: 11148180
    [Abstract] [Full Text] [Related]

  • 17. TRACP 5b and CTX as osteological markers of delayed fracture healing.
    Moghaddam A, Müller U, Roth HJ, Wentzensen A, Grützner PA, Zimmermann G.
    Injury; 2011 Aug 11; 42(8):758-64. PubMed ID: 21168135
    [Abstract] [Full Text] [Related]

  • 18. Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis).
    Alatalo SL, Ivaska KK, Waguespack SG, Econs MJ, Väänänen HK, Halleen JM.
    Clin Chem; 2004 May 11; 50(5):883-90. PubMed ID: 15016726
    [Abstract] [Full Text] [Related]

  • 19. Effects of raloxifene on bone metabolism in postmenopausal women on chronic hemodialysis.
    Nagatoya K, Nishimoto K, Shibahara N, Takahashi T, Kanehara H, Ueno N, Yasuda H, Okada S, Ueda H, Hirai K, Inoue T, Hokusetsu Renal Osteodystrophy Study Group.
    Clin Exp Nephrol; 2015 Oct 11; 19(5):939-46. PubMed ID: 25504368
    [Abstract] [Full Text] [Related]

  • 20. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
    Okuno S, Ishimura E, Tsuboniwa N, Norimine K, Yamakawa K, Yamakawa T, Shoji S, Mori K, Nishizawa Y, Inaba M.
    Osteoporos Int; 2013 Feb 11; 24(2):605-12. PubMed ID: 22581293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.